Several GLP-1 RAs have additional FDA approval for: Heart protection : Dulaglutide [archived link], liraglutide [archived link], and semaglutide [archived link] have been proven to prevent strokes and heart attacks in people with risk factors, such as diabetes or obesity
If your thyroid is not well-managed, adding a GLP-1 could potentially exacerbate constipation or lead to significant nausea
Based on observational data from 200 individuals.
People taking FDA-approved doses of Wegovy for one year and four months lost about 35 pounds, according to the manufacturer
Along the way, youll hear about the biology of the GLP-1 molecule and its related peptides, learn more about how GLP-1 agonists promote glycemic control, weight loss, and cardiometabolic health, and explore the current body of literature supporting the individualized application of these medications to patients with diabetes, obesity, and/or ASCVD